|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.260 USD | -59.35% |
|
-.--% | - |
| 12-16 | Sonnet BioTherapeutics Holdings, Inc. Reports Earnings Results for the Full Year Ended September 30, 2025 | CI |
| 12-02 | Top Midday Decliners | MT |
Company Valuation: Sonnet Biotherapeutics
Data adjusted to current consolidation scope
| Fiscal Period: September | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 35.06 | 35.24 | 7.173 | 5.015 | 4.351 | 31.27 |
| Change | - | 0.5% | -79.64% | -30.09% | -13.25% | 618.74% |
| Enterprise Value (EV) 1 | 28.07 | 7.741 | 4.376 | 2.945 | 4.332 | 26.2 |
| Change | - | -72.42% | -43.47% | -32.72% | 47.12% | 504.7% |
| P/E Ratio | - | - | -0.22x | -0.16x | -0.59x | -1.17x |
| PBR | - | 1.64x | -3.21x | -22.2x | -8.96x | 3x |
| PEG | - | - | - | 0x | 0x | 0x |
| Capitalization / Revenue | - | 72,861,407x | 20,498,415x | 33,929,596x | 233,576,345x | 31,269,272x |
| EV / Revenue | - | - | - | - | - | - |
| EV / EBITDA | -1.61x | -0.31x | -0.15x | -0.16x | -0.37x | -1.65x |
| EV / EBIT | -1.61x | -0.31x | -0.15x | -0.16x | -0.37x | -1.65x |
| EV / FCF | -3.17x | -0.59x | -0.24x | -0.2x | -0.48x | -1.66x |
| FCF Yield | -31.6% | -170% | -414% | -497% | -206% | -60.1% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | - | - | -1,203 | -145.1 | -11.35 | -3.923 |
| Distribution rate | - | - | - | - | - | - |
| Net sales | - | 0.4836 | 0.3499 | 0.1478 | 0.0186 | 1 |
| EBITDA 1 | -17.4 | -25.07 | -29.66 | -18.78 | -11.84 | -15.83 |
| EBIT 1 | -17.41 | -25.09 | -29.67 | -18.79 | -11.85 | -15.84 |
| Net income 1 | -24.27 | -24.98 | -29.72 | -18.83 | -7.437 | -16.01 |
| Net Debt 1 | -6.997 | -27.5 | -2.797 | -2.07 | -0.0186 | -5.074 |
| Reference price 2 | 6,332.484 | 1,493.185 | 258.720 | 22.920 | 6.690 | 4.580 |
| Nbr of stocks (in thousands) | 5.54 | 23.6 | 27.7 | 219 | 650 | 6,827 |
| Announcement Date | 17/12/20 | 17/12/21 | 15/12/22 | 14/12/23 | 17/12/24 | 16/12/25 |
1USD in Million2USD
Estimates
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- SONN Stock
- Valuation Sonnet Biotherapeutics
Select your edition
All financial news and data tailored to specific country editions
